These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective]. Inoue M; Nishino I Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753 [TBL] [Abstract][Full Text] [Related]
13. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701 [TBL] [Abstract][Full Text] [Related]
14. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [TBL] [Abstract][Full Text] [Related]
15. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. Li C; Liu H; Yang L; Liu R; Yin G; Xie Q J Autoimmun; 2024 Sep; 148():103286. PubMed ID: 39033686 [TBL] [Abstract][Full Text] [Related]